Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Colony-Stimulating Factors × 30 days × Clear all

Sponsor

Conditions

Neuroblastoma 3 Triple Negative Breast Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Ganglioneuroblastoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Neoplasm Metastasis 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 12 Rituximab 11 obinutuzumab 9 fludarabine 9 Prednisone 7 ibrutinib 6 Lenalidomide 6 tocilizumab 5 fludarabine phosphate 5 Biopsy 5 venetoclax 4 pirtobrutinib 4 glofitamab 4 Specimen Handling 4 Doxorubicin 4 polatuzumab vedotin 3 X-Rays 3 Vincristine 3 Phantoms, Imaging 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 tucatinib 2 temsirolimus 2 pertuzumab 2 palbociclib 2 olaparib 2 cobimetinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Trastuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡